Walleye Trading LLC Zai Lab LTD Call Options Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $60,420 - $96,200	2,000 New	2,000 $66,000
Q2 2022 Aug 08, 2022	SELL	$23.14 - $49.68 $168,922 - $362,664	-7,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $94,418 - $218,960	-3,400 Reduced 31.78%	7,300 $321,000
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $472,140 - $904,806	8,600 Added 409.52%	10,700 $672,000
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $126,000 - $214,044	-1,200 Reduced 36.36%	2,100 $221,000
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $212,687 - $306,000	1,700 Added 106.25%	3,300 $584,000
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $202,032 - $306,736	1,600 New	1,600 $213,000
Q4 2020 Feb 16, 2021	SELL	$81.94 - $135.34 $155,686 - $257,146	-1,900 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$73.3 - $89.48 $51,310 - $62,636	-700 Reduced 26.92%	1,900 $158,000
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $126,932 - $214,578	2,600 New	2,600 $214,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.59B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.